Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2026-01-20 @ 2:45 AM
Study NCT ID:
NCT05502692
Status:
COMPLETED
Last Update Posted:
2023-05-24
First Post:
2022-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CHARACTERISE - A Cross-sectional, Observational Study to Characterise the Transition to Dolutegravir-based Regimens in South Africa in Terms of the Emergence of Obesity, Viral Re-suppression and Integration Into Routine Programme Care
Sponsor:
University of Witwatersrand, South Africa
Organization: